Contrasting Evogene (EVGN) and Calyxt (CLXT)
Evogene (NASDAQ: EVGN) and Calyxt (NASDAQ:CLXT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.
Earnings and Valuation
This table compares Evogene and Calyxt’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Evogene||$6.54 million||15.04||-$19.59 million||($0.83)||-4.60|
Calyxt has higher revenue, but lower earnings than Evogene.
Insider & Institutional Ownership
31.2% of Evogene shares are owned by institutional investors. Comparatively, 12.6% of Calyxt shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This table compares Evogene and Calyxt’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and recommmendations for Evogene and Calyxt, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Calyxt has a consensus price target of $27.75, suggesting a potential upside of 48.00%. Given Calyxt’s higher possible upside, analysts clearly believe Calyxt is more favorable than Evogene.
Evogene beats Calyxt on 5 of the 9 factors compared between the two stocks.
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd. (Evofuel). It operates through two segments. Its Evogene segment develops seed traits, ag-chemical products, and ag-biological products to improve plant performance. The Company’s Evofuel segment develops species of the castor bean plant for second generation feedstock for biofuel and other industrial uses. Its Crop Enhancement (CE) division is developing two types of products: CE seed traits, are seed traits having improved yield and abiotic stress tolerance, and ag-biologicals, which focuses on microbial-based bio-stimulants. The Company’s Crop Protection (CP) division is developing two types of products: CP seed traits and ag-chemicals.
Calyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.
Receive News & Stock Ratings for Evogene Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene Ltd. and related stocks with our FREE daily email newsletter.